recombinant protein vaccine against SARS-CoV-2（Universidad Nacional de San Martín）

N/A

Report date: 2022/12/24 20:00:29

Base Information

Drug Namerecombinant protein vaccine against SARS-CoV-2（Universidad Nacional de San Martín）
Drug Alias NameN/A
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryArgentina
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversidad Nacional de San MartínNational Council Of Scientific And Technical Research, Argentina
China Registration ClassN/A

Develop Information

Active CompaniesNational Council Of Scientific And Technical Research, ArgentinaUniversidad Nacional de San MartínLaboratorio Pablo Cassara
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A